Cord Blood America CEO Matthew Schissler to Speak at Nevada Development Authority Celebration
LAS VEGAS, June 9 Cord Blood America, Inc. (OTC Bulletin Board: CBAI) (www.cordblood-america.com) co-founder and CEO Matthew Schissler speaks today at a joint media event of the Nevada Development Authority and the Las Vegas Convention and Visitors Authority about the economic advantages for Cord Blood America to move from Southern California to Nevada.
The event, which features the top leaders of the Development Authority, the Convention and Visitors Authority, and Las Vegas city officials, emphasizes that Nevada is now ranked number two in the nation for favorable business climates.
Factors considered in the ranking include state and local taxes, regulatory costs, and health care and energy costs. Nevada has no corporate or personal income tax and works hard to avoid placing unnecessary burdens on entrepreneurship and small business, its officials emphasized.
"I am just incredibly honored to speak from the same podium as the business and political elite from Las Vegas. I express great gratitude to the Nevada Development Authority, a truly exceptional organization, to have highlighted Cord Blood America as an example of the great strides they are taking to increase and diversify the business base of Las Vegas," Mr. Schissler will tell the media event. "These are among the reasons we moved to Nevada and we are very pleased that we did. We have found a workforce that is talented and eager to help a small company grow into an international powerhouse. That is what Cord Blood America is all about and we appreciate the Nevada spirit that allows us to expand and succeed."
Cord Blood America is the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally.
About Cord Blood America
Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.
CONTACT: Paul Knopick E & E Communications 949/707-5365 firstname.lastname@example.org
SOURCE Cord Blood America, Inc.
You May Also Like